Gadolinium Contrast Agents in Magnetic Resonance Imaging (MRI)
Magnetic Resonance Imaging (MRI) has proven to be one of the most powerful clinical diagnostic tools. Based on chemical principles discovered in the 1940s, MRI uses magnetic fields to excite bulk water protons throughout the body, creating an image from their responses. Although useful for the diagnosis of a variety of diseases and conditions, a lack of image clarity can result in incorrect or missed diagnoses. Due to the inherent challenges with MRI, gadolinium-based contrast agents (GBCAs) are used to modulate the response of the bulk water protons to the external magnetic fields, subsequently increasing the image contrast. Here, we discuss GBCAs and their role in overcoming the challenges with magnetic resonance (MR) image clarity.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).